Development and validation of a machine learning‐based model to predict isolated post‐challenge hyperglycemia in middle‐aged and elder adults: Analysis from a multicentric study

Author:

Hou Rui12,Dou Jingtao3ORCID,Wu Lijuan1,Zhang Xiaoyu4,Li Changwei5,Wang Weiqing6,Gao Zhengnan7,Tang Xulei8,Yan Li9,Wan Qin10,Luo Zuojie11,Qin Guijun12,Chen Lulu13,Ji Jianguang14,He Yan1,Wang Wei15ORCID,Mu Yiming3,Zheng Deqiang1ORCID

Affiliation:

1. Department of Epidemiology and Health Statistics School of Public Health Capital Medical University Beijing China

2. Beijing Center for Disease Prevention and Control Beijing China

3. Department of Endocrinology The First Medical Center Chinese PLA General Hospital Beijing China

4. Department of Medicine and Therapeutics The Chinese University of Hong Kong Hong Kong China

5. Department of Epidemiology Tulane University School of Public Health and Tropical Medicine New Orleans Louisiana USA

6. National Clinical Research Center for Metabolic Diseases State Key Laboratory of Medical Genomics Shanghai Clinical Center for Endocrine and Metabolic Diseases Shanghai Institute for Endocrine and Metabolic Diseases Ruijin Hospital Shanghai Jiaotong University School of Medicine Shanghai China

7. Dalian Central Hospital Dalian Liaoning China

8. First Hospital of Lanzhou University Lanzhou Gansu China

9. Zhongshan University Sun Yat‐sen Memorial Hospital Guangzhou Guangdong China

10. Southwest Medical University Affiliated Hospital Luzhou Sichuan China

11. First Affiliated Hospital of Guangxi Medical University Nanning Guangxi China

12. First Affiliated Hospital of Zhengzhou University Zhengzhou Henan China

13. Wuhan Union Hospital Huazhong University of Science and Technology Wuhan Hubei China

14. Center for Primary Health Care Research Lund University/Region Skåne Malmö Sweden

15. Centre for Precision Health Edith Cowan University Perth Western Australia Australia

Abstract

AbstractIntroductionDue to the high cost and complexity, the oral glucose tolerance test is not adopted as the screening method for identifying diabetes patients, which leads to the misdiagnosis of patients with isolated post‐challenge hyperglycemia (IPH), that is., patients with normal fasting plasma glucose (<7.0 mmoL/L) and abnormal 2‐h postprandial blood glucose (≥11.1 mmoL/L). We aimed to develop a model to differentiate individuals with IPH from the normal population.MethodsData from 54301 eligible participants were obtained from the Risk Evaluation of Cancers in Chinese Diabetic Individuals: a longitudinal (REACTION) study in China. Data from 37740 participants were used to develop the diagnostic system. External validation was performed among 16561 participants. Three machine learning algorithms were used to create the predictive models, which were further evaluated by various classification algorithms to establish the best predictive model.ResultsTen features were selected to develop an IPH diagnosis system (IPHDS) based on an artificial neural network. In external validation, the AUC of the IPHDS was 0.823 (95% CI 0.811–0.836), which was significantly higher than the AUC of the Taiwan model [0.799 (0.786–0.813)] and that of the Chinese Diabetes Risk Score model [0.648 (0.635–0.662)]. The IPHDS model had a sensitivity of 75.6% and a specificity of 74.6%. This model outperformed the Taiwan and CDRS models in subgroup analyses. An online site with instant predictions was deployed at https://app‐iphds‐e1fc405c8a69.herokuapp.com/.ConclusionsThe proposed IPHDS could be a convenient and user‐friendly screening tool for diabetes during health examinations in a large general population.

Funder

Natural Science Foundation of Beijing Municipality

Publisher

Wiley

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3